Petros Pharmaceuticals Stock Market Value
| PTPI Stock | USD 0.01 0.0004 5.00% |
| Symbol | Petros |
Petros Pharmaceuticals 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Petros Pharmaceuticals' pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Petros Pharmaceuticals.
| 11/20/2025 |
| 02/18/2026 |
If you would invest 0.00 in Petros Pharmaceuticals on November 20, 2025 and sell it all today you would earn a total of 0.00 from holding Petros Pharmaceuticals or generate 0.0% return on investment in Petros Pharmaceuticals over 90 days. Petros Pharmaceuticals is related to or competes with INVO Fertility, Lixte Biotechnology, Celularity, Longevity Health, Concord Medical, and PetVivo Holdings. Petros Pharmaceuticals, Inc., a pharmaceutical company, focuses on mens health therapeutics More
Petros Pharmaceuticals Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Petros Pharmaceuticals' pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Petros Pharmaceuticals upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.07) | |||
| Maximum Drawdown | 55.0 | |||
| Value At Risk | (12.50) | |||
| Potential Upside | 14.29 |
Petros Pharmaceuticals Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Petros Pharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Petros Pharmaceuticals' standard deviation. In reality, there are many statistical measures that can use Petros Pharmaceuticals historical prices to predict the future Petros Pharmaceuticals' volatility.| Risk Adjusted Performance | (0.04) | |||
| Jensen Alpha | (0.81) | |||
| Total Risk Alpha | (1.21) | |||
| Treynor Ratio | (0.20) |
Petros Pharmaceuticals February 18, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.04) | |||
| Market Risk Adjusted Performance | (0.19) | |||
| Mean Deviation | 6.19 | |||
| Coefficient Of Variation | (1,515) | |||
| Standard Deviation | 9.99 | |||
| Variance | 99.79 | |||
| Information Ratio | (0.07) | |||
| Jensen Alpha | (0.81) | |||
| Total Risk Alpha | (1.21) | |||
| Treynor Ratio | (0.20) | |||
| Maximum Drawdown | 55.0 | |||
| Value At Risk | (12.50) | |||
| Potential Upside | 14.29 | |||
| Skewness | 0.5388 | |||
| Kurtosis | 2.86 |
Petros Pharmaceuticals Backtested Returns
Petros Pharmaceuticals maintains Sharpe Ratio (i.e., Efficiency) of -0.0318, which implies the firm had a -0.0318 % return per unit of risk over the last 3 months. Petros Pharmaceuticals exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check Petros Pharmaceuticals' Variance of 99.79, risk adjusted performance of (0.04), and Coefficient Of Variation of (1,515) to confirm the risk estimate we provide. The company holds a Beta of 3.37, which implies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Petros Pharmaceuticals will likely underperform. At this point, Petros Pharmaceuticals has a negative expected return of -0.33%. Please make sure to check Petros Pharmaceuticals' maximum drawdown, daily balance of power, as well as the relationship between the Daily Balance Of Power and period momentum indicator , to decide if Petros Pharmaceuticals performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.44 |
Average predictability
Petros Pharmaceuticals has average predictability. Overlapping area represents the amount of predictability between Petros Pharmaceuticals time series from 20th of November 2025 to 4th of January 2026 and 4th of January 2026 to 18th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Petros Pharmaceuticals price movement. The serial correlation of 0.44 indicates that just about 44.0% of current Petros Pharmaceuticals price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.44 | |
| Spearman Rank Test | -0.32 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Other Information on Investing in Petros Pink Sheet
Petros Pharmaceuticals financial ratios help investors to determine whether Petros Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Petros with respect to the benefits of owning Petros Pharmaceuticals security.